These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 6285799

  • 21. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
    Paramita DK, Fachiroh J, Haryana SM, Middeldorp JM.
    J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
    [Abstract] [Full Text] [Related]

  • 22. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM.
    J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
    [Abstract] [Full Text] [Related]

  • 23. Serum anti-EBV IgA is inversely related to tumor infiltration by surface IgA positive lymphocytes in nasopharyngeal carcinoma.
    Gunvén P, Klein G, Henle W, Henle G, Forsby N.
    Biomed Pharmacother; 1983 Nov; 37(1):41-4. PubMed ID: 6311307
    [Abstract] [Full Text] [Related]

  • 24. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.
    Liu MY, Huang YT, Sheen TS, Chen JY, Tsai CH.
    J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902
    [Abstract] [Full Text] [Related]

  • 25. Epstein-Barr virus-associated antibodies and serum biochemistry in nasopharyngeal carcinoma.
    Lynn TC, Hsieh RP, Chuang CY, Huang SC, Hsieh T, Tu SM.
    Laryngoscope; 1984 Nov; 94(11 Pt 1):1485-8. PubMed ID: 6092804
    [Abstract] [Full Text] [Related]

  • 26. [EBV-specific antibodies in patients with nasopharyngeal cancer and tonsillar cancer. Follow-up of over 4 years].
    Oberender H, Nowak R, Donner A, Brichacek E, Vonka V, Teterin W, Kunkel M.
    Laryngorhinootologie; 1989 Mar; 68(3):181-5. PubMed ID: 2540762
    [Abstract] [Full Text] [Related]

  • 27. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma].
    Cao SM, Min HQ, Gao JS, Hong MH, Xiao XB, Zhang CQ, Liu XD, Zhang AL, Guo X.
    Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192
    [Abstract] [Full Text] [Related]

  • 28. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, Frikha M, Jlidi R, Middeldorp JM.
    J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
    [Abstract] [Full Text] [Related]

  • 29. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D.
    Chow KC, Ma J, Lin LS, Chi KH, Yen SH, Liu SM, Liu WT, Chen WK, Chang TH, Chen KY.
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):363-8. PubMed ID: 9149897
    [Abstract] [Full Text] [Related]

  • 30. [Atypical involvement of undifferentiated carcinomas of the nasopharyngeal type. Apropos of 3 cases].
    Le Roy A, Honigman I, Chevalier E, Hazan A, Bodiguel V, Adotti F, Peytral C.
    Ann Otolaryngol Chir Cervicofac; 1998 Nov; 115(5):288-92. PubMed ID: 9881177
    [Abstract] [Full Text] [Related]

  • 31. Circulating immune complexes in patients with nasopharyngeal carcinoma.
    Wolf GT, Wolfe RA.
    Laryngoscope; 1990 Mar; 100(3):302-8. PubMed ID: 1689798
    [Abstract] [Full Text] [Related]

  • 32. Histological types of nasopharyngeal carcinoma in an intermediate risk area.
    Cammoun M, Ellouz R, Behi J, Attia RB.
    IARC Sci Publ (1971); 1978 Mar; (20):13-26. PubMed ID: 215511
    [Abstract] [Full Text] [Related]

  • 33. Histopathological types of nasopharyngeal carcinoma in a low-risk area: Japan.
    Sugano H, Sakamoto G, Sawaki S, Hirayama T.
    IARC Sci Publ (1971); 1978 Mar; (20):27-39. PubMed ID: 215515
    [Abstract] [Full Text] [Related]

  • 34. Malaria antibody levels in patients with nasopharyngeal carcinoma.
    Yadav M, Prasad U.
    Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):234-7. PubMed ID: 6095462
    [Abstract] [Full Text] [Related]

  • 35. Epstein-Barr virus DNA in nasopharyngeal carcinoma in Thai patients at Ramathibodi Hospital, Bangkok.
    Niemhom S, Maeda S, Raksakait K, Petchclai B.
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26 Suppl 1():325-8. PubMed ID: 8629135
    [Abstract] [Full Text] [Related]

  • 36. Diagnostic value of Epstein-Barr viral serology in nasopharyngeal carcinoma.
    Low WK, Leong JL, Goh YH, Fong KW.
    Otolaryngol Head Neck Surg; 2000 Oct; 123(4):505-7. PubMed ID: 11020195
    [Abstract] [Full Text] [Related]

  • 37. The association between undifferentiated nasopharyngeal carcinoma and Epstein-Barr virus shown by correlated nucleic acid hybridization and histopathological studies.
    Andersson-Anvret M, Klein G, Forsby N, Henle W.
    IARC Sci Publ (1971); 1978 Oct; (20):347-57. PubMed ID: 83285
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. IgA/VCA as a follow-up marker in the monitoring of nasopharyngeal carcinoma.
    Sam CK, Abu-Samah AJ, Prasad U.
    Eur J Surg Oncol; 1994 Oct; 20(5):561-4. PubMed ID: 7926060
    [Abstract] [Full Text] [Related]

  • 40. Epstein-Barr virus serology in the control of nasopharyngeal carcinoma.
    Levine PH, Connelly RR, Milman G, Easton J.
    Cancer Detect Prev; 1988 Oct; 12(1-6):357-62. PubMed ID: 2846170
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.